PWS
CMD

Peloton Wealth Strategists’s Cantel Medical Corporation CMD Stock Holding History

Peloton Wealth Strategists’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-17,800
Closed -$639K – 75
2020
Q1 		$639K Sell
17,800
-16,150
-48% -$918K 0.52% 57
2019
Q4 		$2.41M Sell
33,950
-2,100
-6% -$152K 1.46% 31
2019
Q3 		$2.7M Buy
36,050
+3,100
+9% +$263K 1.72% 26
2019
Q2 		$2.66M Buy
32,950
+950
+3% +$66.8K 1.78% 26
2019
Q1 		$2.14M Buy
32,000
+11,800
+58% +$894K 1.48% 34
2018
Q4 		$1.5M Buy
+20,200
New +$1.67M 1.22% 40

Other funds holding CMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
LGP
Leonard Green & Partners Los Angeles, California $2.77B AUM 3.28% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Peloton Wealth Strategists's CMD Position: Q2 2020 in Review

Peloton Wealth Strategists sold out of Cantel Medical Corporation (CMD) in Q2 2020, closing a stake of 17,800 shares — an estimated $639K sold.

Peloton Wealth Strategists first reported a position in CMD in Q4 2018 and held it in 6 quarters. The position peaked at $2.7M in Q3 2019. 210 funds tracked by Wall St. Rank hold CMD as of Q2 2020.

  • Peloton Wealth Strategists reported no remaining Cantel Medical Corporation position as of Q2 2020 after selling out during the quarter.
  • Peloton Wealth Strategists sold 17,800 Cantel Medical Corporation shares in Q2 2020, an estimated $639K.
  • Peloton Wealth Strategists first reported a position in Cantel Medical Corporation in Q4 2018 and held it in 6 quarters.
  • Peloton Wealth Strategists's Cantel Medical Corporation position peaked at $2.7M in Q3 2019.
  • 210 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2020.

Based on Peloton Wealth Strategists's 13F filing for Q2 2020, filed 13 Aug 2020.